← Back to Patent Explorer
US4604379A Expired / Lapsed US ⏱️ 0.0 years remaining

Dialysis solutions containing cross-linked gelatin

Assignee: University of Missouri System
•
Filing: 1984-06-18
•
Granted: 1986-08-05
•
Expires: 2004-06-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Peritoneal dialysis solution may have an osmotic agent as a partial or complete substitute to the conventional dextrose. The osmotic agent is gelatin chemically cross-linked to suppress gelation.

Inventors

  • 👤 Zbylut J. Twardowski
  • 👤 Karl D. Nolph

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:45
CPC Classifications
A; A61; A61K; A61K33/00; A61K38/00; A61K38/16; A61K38/17; A61K38/39; A61M; A61M1/00; A61M1/14; A61M1/28; A61M1/287; G; G03; G03C; G03C1/00; G03C1/005; G03C1/04; G03C1/047; G03C2001/0471

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 109 words
A peritoneal dialysis solution comprising an osmotic agent operative, when said solution is present in the peritoneal cavity, to induce and sustain the ultrafiltration of water from the blood into said solution through the peritoneum, said osmotic agent comprising gelatin which is chemically cross-linked to suppress gelatin and which has an isoelectric point at a pH below about 5, said cross-linked gelatin being essentially free of synthetically added, pendant ionizable groups, and a quantity of physiological cations present to maintain said solution at a pH above about 5 to create a normally anionic charge on said cross-linked gelatin and to cause said cross-linked gelatin to assume a salt form.
Claim 2
Dependent Claim 109 words
A peritoneal dialysis solution comprising an osmotic agent operative, when said solution is present in the peritoneal cavity, to induce and sustain the ultrafiltration of water from the blood into said solution through the peritoneum, said osmotic agent comprising gelatin which is chemically cross-linked to suppress gelatin and which has an isoelectric point at a pH below about 5, said cross-linked gelatin being essentially free of synthetically added, pendant ionizable groups, and a quantity of physiological cations present to maintain said solution at a pH above about 5 to create a normally anionic charge on said cross-linked gelatin and to cause said cross-linked gelatin to assume a salt form.
Claim 3
Dependent Claim 24 words
The peritoneal dialysis solution of claim 1 in which said physiological cations are selected from the group consisting of sodium, magnesium, potassium, and calcium.
Claim 4
Dependent Claim 22 words
The peritoneal dialysis solution of claim 1 in which said cross-linked gelatin is the reaction product of gelatin and an aliphatic diisocyanate.
Claim 5
Dependent Claim 21 words
The peritoneal dialysis solution of claim 1 in which said cross-linked gelatin is the reaction product of gelatin and dialdehyde glyoxal.
Claim 6
Dependent Claim 13 words
The peritoneal dialysis solution of claim 1 which has a pH of 6.0-7.5.
Claim 7
Dependent Claim 15 words
The peritoneal dialysis solution of claim 1 which contains dextrose as an added osmotic agent.

References Cited (Backward Citations)

CA546929A Cited
US3057782A Cited
US4339433A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-08-04 1990-02-03 1990-08-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-08-04 1994-02-03 1994-08-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-08-04 1998-02-03 1998-08-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag